🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

26 recruiting trials

for Kaposi Sarcoma

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease NCT05907759Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Daratumumab SC Precision Imaging to Evaluate Kaposi Sarcoma NCT06898203NA2 sites📍 Kisumu📍 Kampala Washington University School of Medicine · Tests: SkinScan3D Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS) NCT06052618Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Pacritinib Nirogacestat in Patients With Kaposi Sarcoma NCT07539454Phase 21 site📍 St Louis AIDS Malignancy Consortium · Tests: Biospecimen Collection, Chest Radiography, Computed Tomography, Nirogacestat, Skin Biopsy A Study of Propranolol to Treat Kaposi Sarcoma NCT05797662Phase 26 sites📍 Buenos Aires📍 Rio de Janeiro📍 Salvador AIDS Malignancy Consortium · Tests: Propranolol Propranolol for the Treatment of Kaposi Sarcoma in Adults NCT06445166Phase 21 site📍 St Louis Washington University School of Medicine · Tests: Propranolol Hydrochloride Natural History Study of Kaposi Sarcoma NCT06375122n/a1 site📍 Bethesda National Cancer Institute (NCI) New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease NCT07793006NA1 site📍 Lilongwe Indiana University · Tests: Lymph Node or Core Needle Biopsy, Fine Needle Aspiration, Tiny Isothermal Nucleic acid Amplification System (TINY) PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma NCT04303117Phase 1, Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: PDS01ADC, M7824 Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas NCT07066982Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: CD146/HER2 CAR-T cells Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV) NCT07308886Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: CYT107 Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma NCT04941274Phase 1, Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Abemaciclib Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers NCT05663502n/a8 sites📍 La Jolla📍 San Francisco📍 Washington D.C. AIDS Malignancy Consortium · Tests: Biospecimen Collection Trial of Ixazomib for Kaposi Sarcoma NCT04305691Phase 211 sites📍 San Diego📍 San Francisco📍 Miami AIDS Malignancy Consortium · Tests: Ixazomib Citrate, Quality-of-Life Assessment, Questionnaire Administration The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus NCT06236022Phase 41 site📍 Wuhan Tongji Hospital · Tests: Sirolimus A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer NCT05859074Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: MQ719, Pembrolizumab Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. NCT03889899NA1 site📍 Haifa Alpha Tau Medical LTD. · Tests: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) Study of SGR-1505 in Mature B-Cell Neoplasms NCT05544019Phase 136 sites📍 Gilbert📍 Newark📍 Pompano Beach Schrödinger, Inc. · Tests: SGR-1505 Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease NCT03300830n/a1 site📍 Bethesda National Cancer Institute (NCI) Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial NCT06751355n/a1 site📍 St Louis Washington University School of Medicine · Tests: SkinScan3D camera Natural History of KSHV-Associated Multicentric Castleman s Disease NCT04968288n/a1 site📍 Bethesda National Cancer Institute (NCI) Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer NCT00006518n/a1 site📍 Bethesda National Cancer Institute (NCI) Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia NCT04534127NA1 site📍 Jerusalem Alpha Tau Medical LTD. · Tests: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS) NCT01419561Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Zidovudine, Liposomal Doxorubicin, Valganiclovir, Rituximab, Standard Therapies AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW) NCT06004011NA1 site📍 Lusaka Implenomics · Tests: ARROW strategies, One-time education Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV NCT04902443Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: Pomalidomide, Nivolumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy